Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline.

Marco TuccoriDaniele Focosi


Monoclonal antibody (mAb) therapy has been previously exploited for viral infections, such as respiratory syncytial virus pneumonia and Ebolavirus disease. In the ongoing COVID-19 pandemic, early signals of efficacy from convalescent plasma therapy have encouraged research and development of anti-SARS-CoV-2 mAbs. While many candidates are in preclinical development, we focus here on anti-SARS-CoV-2 neutralizing mAbs (or mAb cocktails) that represent the late-stage clinical pipeline, i.e., those currently in Phase 2 or Phase 3 clinical trials. We describe the structure, mechanism of action, and ongoing trials for VIR-7831, LY-CoV555, LY-CoV016, BGB-DXP593, REGN-COV2, and CT-P59. We speculate also on the next generation of these mAbs.


Apr 7, 2006·The Journal of Biological Chemistry·Ponraj PrabakaranDimiter S Dimitrov
May 2, 2013·The Cochrane Database of Systematic Reviews·Tea AndabakaBruno Barsic
Jun 4, 2018·The Journal of Infectious Diseases·Kristen E PascalChristos A Kyratsous
Nov 28, 2019·The New England Journal of Medicine·Sabue MulanguUNKNOWN PALM Consortium Study Team
Jun 13, 2020·Critical Care : the Official Journal of the Critical Care Forum·Irma ConvertinoCorrado Blandizzi
Jun 24, 2020·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marco TuccoriCorrado Blandizzi
Jun 27, 2020·BioRxiv : the Preprint Server for Biology·Lizhou ZhangHyeryun Choe
Jul 15, 2020·Nature Nanotechnology·Helena F FlorindoRonit Satchi-Fainaro
Jul 15, 2020·JAMA : the Journal of the American Medical Association·Jennifer Abbasi
Aug 15, 2020·Clinical Microbiology Reviews·Daniele FocosiMarco Tuccori
Sep 5, 2020·European Journal of Immunology·Kanta SubbaraoRajeev Rudraraju
Sep 17, 2020·BMJ : British Medical Journal·Elisabeth Mahase
Sep 30, 2020·Cytotherapy·Kuttuvan Valappil Sajna, Siya Kamat
Oct 3, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Daniele FocosiFabrizio Maggi
Oct 17, 2020·ACS Pharmacology & Translational Science·Dhanusha A Nalawansha, Kusal T G Samarasinghe
Oct 20, 2020·ACS Pharmacology & Translational Science·Michael S Kinch
Oct 29, 2020·The New England Journal of Medicine·Peter ChenUNKNOWN BLAZE-1 Investigators
Nov 12, 2020·MedRxiv : the Preprint Server for Health Sciences·Jéromine KlinglerCatarina E Hioe

❮ Previous
Next ❯


Feb 9, 2021·Journal of Ovarian Research·Antonio MacciòClelia Madeddu
Feb 16, 2021·AIDS Research and Human Retroviruses·Monty Montano
Apr 7, 2021·Science Translational Medicine·Bryan E JonesEster Falconer
May 1, 2021·Viruses·Aeron C Hurt, Adam K Wheatley
Apr 20, 2021·Microbes and Infection·Md Alamgir KabirWaseem Asghar
May 11, 2021·Frontiers in Molecular Biosciences·Long Min, Qiu Sun
Jun 3, 2021·Antioxidants·Alessio Danilo InchingoloFrancesco Inchingolo
May 19, 2021·Acta Pharmaceutica Sinica. B·Zinuo ChenQinghua Cui
Jul 3, 2021·Viruses·Ahlam ChaqrounEvelyne Schvoerer
Jul 3, 2021·International Journal of Molecular Sciences·Jonothan Rosario-ColonHong Xin
Jul 29, 2021·Clinical Microbiology Reviews·Kaiming TaoRobert W Shafer
Aug 19, 2021·Nature Communications·Yanyun DuJinghua Yan
Sep 10, 2021·Cellular & Molecular Immunology·Lanying DuXiujuan Zhang
Oct 4, 2021·International Journal of Medical Informatics·Thomas W CampbellKristine M Erlandson
Oct 14, 2021·Computational and Structural Biotechnology Journal·Didac MartíCarlos Alemán

❮ Previous
Next ❯

Methods Mentioned

single-cell sequencing
phage display

Clinical Trials Mentioned


Software Mentioned

Google Scholar

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Satoshi KutsunaAkihiro Matsunaga
The New England Journal of Medicine
Evangelos TerposMeletios A Dimopoulos
The New England Journal of Medicine
Edwin BölkeJohannes C Fischer
© 2021 Meta ULC. All rights reserved